Morgan Keegan is out with its report today on Trustmark TRMK, maintaining Outperform.
In a note to clients, Morgan Keegan writes, "TRMK shares remain undervalued despite its solid balance sheet position, strong PTPP earnings and below average credit risk. At 12.3x our 2012 EPS estimate shares trade at a 13% discount to the 14.1x median of the MK small-cap banks.TRMK also offers an extremely attractive 3.9% dividend yield, almost double the 2.1% median of peers."
Morgan Keegan has a $27 PT on TRMK.
Shares of TRMK closed Friday at $23.34.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in